During the past decade, Zentrum f. klinische Studien Dr. Hanusch GmbH conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zentrum f. klinische Studien Dr. Hanusch GmbH" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Bayer" with 4 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored, "Martin Huelsmann" with 1 trials sponsored and "Megainpharm GmbH" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zentrum f. klinische Studien Dr. Hanusch GmbH" #1 collaborator was "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Zentrum f. klinische Studien Dr. Hanusch GmbH" are "Chronic Kidney Disease" (4 trials), "Diabetes Mellitus, Type 2" (2 trials), "Obesity" (2 trials), "Overweight" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Zentrum f. klinische Studien Dr. Hanusch GmbH" in a lesser frequency.

Most popular intervention types in "Zentrum f. klinische Studien Dr. Hanusch GmbH" are "Drug" (12 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Tirzepatide" (3 trials), "Dulaglutide" (2 trials), "Adalimumab" (1 trials) and "BAY2327949" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zentrum f. klinische Studien Dr. Hanusch GmbH" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Zentrum f. klinische Studien Dr. Hanusch GmbH". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Zentrum f. klinische Studien Dr. Hanusch GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Zentrum f. klinische Studien Dr. Hanusch GmbH, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".